Join the club for FREE to access the whole archive and other member benefits.

Matthew Hobbs

Deputy Director of Research at Prostate Cancer UK

Matthew Hobbs joined Prostate Cancer UK as Deputy Director of Research in November 2013. Through a period where the charity’s focus has increasingly been placed on funding and translating research that can make a difference for men diagnosed with or at risk of prostate cancer. Matthew has been responsible for in-year delivery of the charity’s research business plans; has contributed to development of new charity and research strategies; and, with his team, has delivered several targeted research funding schemes and changed how the charity performs horizon scanning, impact assessment, and response mode funding. Matthew’s previous roles include: Head of Research at Diabetes UK between January 2012 and November 2013; Senior Project Manager for the NIHR Manchester Biomedical Research Centre (January 2010 – December 2011) and a Knowledge Transfer Partnership to develop better tools for the NHS to support commercial clinical trials (January 2008 – January 2010). In the very distant past he completed a PhD involving the synthesis of lanthanide complexes of which he now understands barely a single word!

Visit website: https://www.ncri.org.uk/trustees/dr-matthew-hobbs/

 matthew-hobbs-152583a

 matthew_hobbs

See also: Company Prostate Cancer UK - Care for people with prostate cancer.

Details last updated 25-Oct-2019

Matthew Hobbs News

Newer diagnostic techniques reduced unnecessary harm in prostate cancer testing

Newer diagnostic techniques reduced unnecessary harm in prostate cancer testing

Independent - 23-Feb-2023

67% fewer men experienced risks of screening with advanced diagnostic techniques

New drug slowed tumour growth in men with prostate cancer

New drug slowed tumour growth in men with prostate cancer

BBC - 30-Sep-2019

Olaparib delays cancer growth by months, which means the increased lifespan